|
1
|
Abramyuk A, Appold S, Zöphel K, et al:
Quantitative modifications of TNM staging, clinical staging and
therapeutic intent by FDG-PET/CT in patients with non small cell
lung cancer scheduled for radiotherapy - a retrospective study.
Lung Cancer. 78:148–152. 2012. View Article : Google Scholar
|
|
2
|
Vaidya M, Creach KM, Frye J, et al:
Combined PET/CT image characteristics for radiotherapy tumor
response in lung cancer. Radiother Oncol. 102:239–245. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Satoh Y, Nambu A, Onishi H, et al: Value
of dual time point F-18 FDG-PET/CT imaging for the evaluation of
prognosis and risk factors for recurrence in patients with stage I
non-small cell lung cancer treated with stereotactic body radiation
therapy. Eur J Radiol. 81:3530–3534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greco C, Rosenzweig K, Cascini GL and
Tamburrini O: Current status of PET/CT for tumour volume definition
in radiotherapy treatment planning for non-small cell lung cancer
(NSCLC). Lung Cancer. 57:125–134. 2007.
|
|
5
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. 7th ed. Springer Verlag; New York, NY:
2009
|
|
6
|
Bradley J, Bae K, Choi N, et al: A phase
II comparative study of gross tumor volume definition with or
without PET/CT fusion in dosimetric planning for non-small-cell
lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology
Group (RTOG) 0515. Int J Radiat Oncol Biol Phys. 82:435–441.
2012.
|
|
7
|
Paulino AC, Thorstad WL and Fox T: Role of
fusion in radiotherapy treatment planning. Semin Nucl Med.
33:2338–2343. 2003. View Article : Google Scholar
|
|
8
|
Abramyuk A, Appold S, Zöphel K, et al:
Modification of staging and treatment of head and neck cancer by
FDG-PET/CT prior to radiotherapy. Strahlenther Onkol. 189:197–201.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mac Manus MP and Hicks RJ: The role of
positron emission tomography/computed tomography in radiation
therapy planning for patients with lung cancer. Semin Nucl Med.
42:308–319. 2012.PubMed/NCBI
|
|
10
|
Buijsen J, van den Bogaard J, van der
Weide H, et al: FDG-PET-CT reduces the interobserver variability in
rectal tumor delineation. Radiother Oncol. 102:371–376. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Baardwijk A, Baumert B, Bosmans G, et
al: The current status of FDG-PET in tumour volume definition in
radiotherapy treatment planning. Cancer Treat Rev. 32:245–260.
2006.PubMed/NCBI
|
|
12
|
Pakzad F, Groves A and Ell PJ: The role of
positron emission tomography in the management of pancreatic
cancer. Semin Nucl Med. 36:248–256. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fleckenstein J, Hellwig D, Kremp S, et al:
F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with
concomitant chemotherapy: results of the PET-PLAN pilot trial. Int
J Radiat Oncol Biol Phys. 81:e283–e289. 2011. View Article : Google Scholar
|
|
14
|
Rodríguez N, Sanz X, Trampal C, et al:
18F-FDG PET definition of gross tumor volume for radiotherapy of
lung cancer: is the tumor uptake value-based approach appropriate
for lymph node delineation? Int J Radiat Oncol Biol Phys.
78:659–666. 2010.
|
|
15
|
Biehl KJ, Kong FM, Dehdashti F, et al:
18F-FDG PET definition of gross tumor volume for radiotherapy of
non-small cell lung cancer: is a single standardized uptake value
threshold approach appropriate? J Nucl Med. 47:1808–1812. 2006.
|
|
16
|
Bradley J, Thorstad WL, Mutic S, et al:
Impact of FDG-PET on radiation therapy volume delineation in
non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 59:78–86.
2004.PubMed/NCBI
|
|
17
|
MacManus MP, Hicks RJ, Matthews JP, et al:
High rate of detection of unsuspected distant metastases by PET in
apparent stage III non-small-cell lung cancer: Implications for
radical radiation therapy. Int J Radiat Oncol Biol Phys.
50:287–293. 2001. View Article : Google Scholar
|
|
18
|
Hong R, Halama J, Bova D, et al:
Correlation of PET standard uptake value and CT window-level
thresholds for target delineation in CT-based radiation treatment
planning. Int J Radiat Oncol Biol Phys. 67:720–726. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Daisne JF, Sibomana M, Bol A, et al:
Tri-dimensional automatic segmentation of PET volumes based on
measured source-to-background rations: influence of reconstruction
algorithms. Radiother Oncol. 69:247–250. 2003.
|
|
20
|
Giraud P, Grahek D, Montravers F, et al:
CT and (18 F-deoxyglucose (FDG) image fusion for optimization of
conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol
Phys. 49:1249–1257. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nestle U, Walter K, Schmidt S, et al:
18F-deoxyglucose positron emission tomography (FDGPET) for the
planning of radiotherapy in lung cancer: high impact in patients
with atelectasis. Int J Radiat Oncol Biol Phys. 44:593–597. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deniaud-Alexandre E, Touboul E, Lerouge D,
et al: Impact of computed tomography and 18F-deoxyglucose
coincidence detection emission tomography image fusion for
optimization of conformal radiotherapy in non-small-cell lung
cancer. Int J Radiat Oncol Biol Phys. 63:1432–1441. 2005.
View Article : Google Scholar
|
|
23
|
Ciernik IF, Dizendorf E, Baumert BG, et
al: Radiation treatment planning with an integrated positron
emission and computer tomography (PET/CT): a feasibility study. Int
J Radiat Oncol Biol Phys. 57:853–863. 2003. View Article : Google Scholar
|
|
24
|
Ceresoli GL, Cattaneo GM, Castellone P, et
al: Role of computed tomography and [18F]
fluorodeoxyglucose positron emission tomography image fusion in
conformal radiotherapy of non-small cell lung cancer: a comparison
with standard techniques with and without elective nodal
irradiation. Tumori. 93:88–96. 2007.
|
|
25
|
Vanuytsel LJ, Vansteenkiste JF, Stroobants
SG, et al: The impact of (18)F-fluoro-2-deoxy-D-glucose1432
positron emission tomography (FDG-PET) lymph node staging on the
radiation treatment volumes in patients with non-small cell lung
cancer. Radiother Oncol. 55:317–324. 2000.
|
|
26
|
van Der Wel A, Nijsten S, Hochstenbag M,
et al: Increased therapeutic ratio by 18FDG-PET CT planning in
patients with clinical CT stage N2–N3M0 non-small cell lung cancer:
a modeling study. Int J Radiat Oncol Biol Phys. 61:649–655.
2005.PubMed/NCBI
|
|
27
|
Nestle U, Hellwig D, Schmidt S, et al:
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in
target volume definition for radiotherapy of patients with
non-small-cell lung cancer. Mol Imaging Biol. 4:257–263. 2002.
|
|
28
|
De Ruysscher D, Wanders S, van Haren E, et
al: Selective mediastinal node irradiation based on FDG-PET scan
data in patients with non-small-cell lung cancer: a prospective
clinical study. Int J Radiat Oncol Biol Phys. 62:988–994.
2005.PubMed/NCBI
|
|
29
|
Faria SL, Menard S, Devic S, Sirois C, et
al: Impact of FDG-PET/CT on radiotherapy volume delineation in
non-small-cell lung cancer and correlation of imaging stage with
pathologic findings. Int J Radiat Oncol Biol Phys. 70:1035–1038.
2008.PubMed/NCBI
|
|
30
|
Ashamalla H, Rafla S, Parikh K, et al: The
contribution of integrated PET/CT to the evolving definition of
treatment volumes in radiation treatment planning in lung cancer.
Int J Radiat Oncol Biol Phys. 63:1016–1023. 2005.PubMed/NCBI
|
